<DOC>
	<DOCNO>NCT00377637</DOCNO>
	<brief_summary>This 2 arm study assess efficacy Mycophenolate Mofetil ( MMF ; CellCept ) compare cyclophosphamide induce response patient lupus nephritis , long term efficacy MMF compare azathioprine maintain remission renal function . Patients randomize receive either MMF ( 1.5 g twice daily [ bid ] ) cyclophosphamide ( 0.5-1.0 g/m^2 monthly pulse ) induction phase . Those patient meet criteria response re-randomized entry maintenance phase , receive either MMF ( 1 g bid ) azathioprine ( 2 mg/kg/day ) .</brief_summary>
	<brief_title>A Study Mycophenolate Mofetil ( CellCept ) Management Patients With Lupus Nephritis .</brief_title>
	<detailed_description />
	<mesh_term>Nephritis</mesh_term>
	<mesh_term>Lupus Nephritis</mesh_term>
	<mesh_term>Cyclophosphamide</mesh_term>
	<mesh_term>Mycophenolate mofetil</mesh_term>
	<mesh_term>Azathioprine</mesh_term>
	<mesh_term>Mycophenolic Acid</mesh_term>
	<criteria>male female patient , 1275 year age ; diagnosis systemic lupus erythematosus ; kidney biopsy within 6 month study , histological diagnosis lupus nephritis ; laboratory evidence active nephritis . continuous dialysis start &gt; 2 week randomization induction phase , and/or anticipate duration &gt; 8 week ; previous plan kidney transplant ; clinically significant active medical condition .</criteria>
	<gender>All</gender>
	<minimum_age>12 Years</minimum_age>
	<maximum_age>75 Years</maximum_age>
	<verification_date>October 2011</verification_date>
</DOC>